Shaperon Inc. Logo

Shaperon Inc.

Clinical-stage biotech developing immune therapeutics for inflammatory diseases.

378800 | KO

Overview

Corporate Details

ISIN(s):
KR7378800007
LEI:
Country:
South Korea
Address:
서울특별시 강남구 자곡로 174-10 강남에이스타워 606호(자곡동), 서울특별시

Description

Shaperon Inc. is a clinical-stage biotechnology company that develops novel immune therapeutics for inflammatory diseases. The company's primary focus is on the development of innovative inflammasome inhibitors. Its core technology is based on a unique mechanism that modulates the GPCR19-P2X7 pathway to regulate the initiation and progression of inflammatory responses. This approach is applied to a pipeline of drug candidates targeting various inflammation-driven conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-07-10 00:00
주식등의대량보유상황보고서(약식)
Korean 57.4 KB
2023-07-10 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 8.6 KB
2023-05-15 00:00
분기보고서 (2023.03)
Korean 1006.6 KB
2023-04-10 00:00
주식등의대량보유상황보고서(약식)
Korean 57.4 KB
2023-03-30 00:00
정기주주총회결과
Korean 22.0 KB
2023-03-30 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 8.7 KB
2023-03-30 00:00
[기재정정]주식매수선택권부여에관한신고
Korean 16.8 KB
2023-03-21 00:00
감사보고서제출
Korean 18.0 KB
2023-03-21 00:00
사업보고서 (2022.12)
Korean 1.2 MB
2023-03-15 00:00
주주총회소집공고
Korean 124.6 KB
2023-03-15 00:00
주주총회집중일개최사유신고
Korean 5.5 KB
2023-03-10 00:00
주주총회소집결의
Korean 9.2 KB
2023-02-15 00:00
주식매수선택권부여에관한신고
Korean 14.4 KB
2023-01-02 00:00
대표이사변경
Korean 9.0 KB
2023-01-02 00:00
주식등의대량보유상황보고서(일반)
Korean 83.2 KB

Automate Your Workflow. Get a real-time feed of all Shaperon Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Shaperon Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Shaperon Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.